Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.22.2.2
Summary of Significant Accounting Policies (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
segment
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Property, Plant and Equipment [Line Items]          
Number of operating segments | segment     1    
Cash and cash equivalents and investments $ 376,600,000   $ 376,600,000    
Restricted cash 700,000   700,000   $ 300,000
Revenues 55,779,000 $ 14,667,000 105,595,000 $ 22,201,000  
Accounts receivable, net 41,771,000   41,771,000   15,414,000
Allowance for doubtful accounts 0   0   $ 0
Upfront license and milestone expense     0 10,000,000  
Upfront license payment     0 $ (6,000,000)  
Otuska          
Property, Plant and Equipment [Line Items]          
Accounts receivable, net $ 28,800,000   28,800,000    
Milestone Achievement          
Property, Plant and Equipment [Line Items]          
Revenues     $ 30,000,000    
Minimum          
Property, Plant and Equipment [Line Items]          
Receivable standard credit terms (in days)     30 days    
Maximum          
Property, Plant and Equipment [Line Items]          
Receivable standard credit terms (in days)     45 days    
Customer Concentration Risk | Revenue Benchmark | Specialty Pharmacy One | United States          
Property, Plant and Equipment [Line Items]          
Concentration risk (as percent) 48.00%   74.00%    
Customer Concentration Risk | Revenue Benchmark | Specialty Pharmacy One | Outside United States          
Property, Plant and Equipment [Line Items]          
Concentration risk (as percent) 52.00%   26.00%